E. A. Hawse Health Center, Inc. in Baker, WV - Clinic/Center

E. A. Hawse Health Center, Inc. is a primary clinic (Clinic/center - Federally Qualified Health Center (fqhc)) in Baker, West Virginia. The current practice location for E. A. Hawse Health Center, Inc. is 238 Cougar Drive, Baker, West Virginia. For appointments, you can reach them via phone at (304) 897-5970. The mailing address for E. A. Hawse Health Center, Inc. is Po Box 97, Baker, West Virginia and phone number is (304) 897-5915.

E. A. Hawse Health Center, Inc. is licensed to practice in * (Not Available) (license number ) and its NPI number is 1053891598. This medical practice does not participate in medicare program and thus may not accept your medicare insurance. You may check if they accept your insurance at (304) 897-5970.

Contact Information

	E. A. Hawse Health Center, Inc.
	238 Cougar Drive Baker WV 26801
	(304) 897-5970
	Not Available

Primary Care Clinic Profile

Full Name	E. A. Hawse Health Center, Inc.
Speciality	Clinic/center - Federally Qualified Health Center (fqhc)
Location	238 Cougar Drive, Baker, West Virginia
Authorized Official Name and Position	Brenda Leigh Thompson (ADMINISTRATIVE ASSISTANT)
Authorized Official Contact	3048975915
Accepts Medicare Insurance	This clinic does not participate in Medicare Program.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
E. A. Hawse Health Center, Inc. Po Box 97 Baker WV 26801-0097 Ph: (304) 897-5915	E. A. Hawse Health Center, Inc. 238 Cougar Drive Baker WV 26801 Ph: (304) 897-5970

NPI Details:

NPI Number	1053891598
Provider Enumeration Date	08/15/2018
Last Update Date	07/07/2020

Medical Identifiers

Medical identifiers for E. A. Hawse Health Center, Inc. such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1053891598	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Q00000X	Family Medicine	(West Virginia)	Secondary
261QF0400X	Clinic/center - Federally Qualified Health Center (fqhc)	(* (Not Available))	Primary

News Archive

Repros commences randomization in Androxal Phase II study in T2DM men with low testosterone

Repros Therapeutics Inc. today announced it has commenced randomization of subjects into its Phase II Androxal® study in the treatment of type 2 diabetes (T2DM) in men with low testosterone. Low testosterone and T2DM are co-morbid conditions in a significant number of men. The study is being conducted at nine sites across the US including both academic and private practices and will enroll up to 150 patients.

Epilepsy drug phenytoin causes bone loss in young women

Young women who took the commonly used epilepsy drug phenytoin for one year showed significant bone loss compared to women taking other epilepsy drugs, according to a study published in the April 29, 2008, issue of Neurology, the medical journal of the American Academy of Neurology.

Proportion of young female anesthesiologists increases, but payment still lower than male peers

An increasing number of young female physicians are becoming anesthesiologists, but the pay of those women lags behind their male peers, even after accounting for differences such as hours worked and experience, according to a new RAND Corporation study.

A new study reveals the secrets of mucus production that could be applied to cancer biology

The cells that produce mucus are known to be involved in serious health conditions such as asthma, chronic obstructive pulmonary disease, and even cancer.

E. A. Hawse Health Center, Inc. - Primary Care in Baker, WV